Healthcare News

SEATTLE, July 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced a symposium...

New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy® System in...

PHOENIX, July 01, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing...

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), empresa de tecnología verde industrial especializada en el desarrollo de soluciones microbiológicas naturales basadas en la...

Chassieu, 01 juill. 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), greentech industrielle spécialisée dans le développement de solutions microbiologiques naturelles basées sur...

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), greentech industriale specializzata nello sviluppo di soluzioni microbiologiche naturali basate sullo sfruttamento...

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba (FR0011051598 - ALMIB), een industrieel greentech-bedrijf gespecialiseerd in de ontwikkeling van natuurlijke microbiologische oplossingen op basis...

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) -- Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA Chassieu (França), 30 de junho de 2026 – 7h30 - A Amoéba...